Cargando…
Clearance of senescent cells with ABT-263 improves biological functions of synovial mesenchymal stem cells from osteoarthritis patients
BACKGROUND: Osteoarthritis (OA) is an age-related joint disease characterized by progressive cartilage loss. Synovial mesenchymal stem cells (MSCs) are anticipated as a cell source for OA treatment; however, synovial MSC preparations isolated from OA patients contain many senescent cells that inhibi...
Autores principales: | Miura, Yugo, Endo, Kentaro, Komori, Keiichiro, Sekiya, Ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166575/ https://www.ncbi.nlm.nih.gov/pubmed/35658936 http://dx.doi.org/10.1186/s13287-022-02901-4 |
Ejemplares similares
-
Clearance of therapy‐induced senescent tumor cells by the senolytic ABT‐263 via interference with BCL‐X(L)–BAX interaction
por: Saleh, Tareq, et al.
Publicado: (2020) -
Navitoclax (ABT263) reduces inflammation and promotes chondrogenic phenotype by clearing senescent osteoarthritic chondrocytes in osteoarthritis
por: Yang, Hao, et al.
Publicado: (2020) -
Mesenchymal stem cells in synovial fluid increase in number in response to synovitis and display more tissue-reparative phenotypes in osteoarthritis
por: Furuoka, Hideto, et al.
Publicado: (2023) -
Comparison of the effects of oxidative and inflammatory stresses on rat chondrocyte senescence
por: Yagi, Misaki, et al.
Publicado: (2023) -
Comparison of the yields and properties of dedifferentiated fat cells and mesenchymal stem cells derived from infrapatellar fat pads
por: Fujii, Shunichi, et al.
Publicado: (2022)